Neil Harris Cohen, Director at Chemomab Therapeutics Ltd. (CMMB), sold 2,304 shares at $2.85 ($7K) on 2026-08-27, disclosed to the SEC on 2026-09-01.
Open-market sale of $7k CMMB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 1,304 | $4K | 57.0% |
| 2 | $2.80 | 1,000 | $3K | 43.0% |
| Total | $2.83 avg | 2,304 | $7K | 100% |
| Filing → |
| CMMB | BUY | 2022-03-15 | $26K | — | Filing → |
| CMMB | BUY | 2021-12-08 | $15K | — | Filing → |
| CMMB | BUY | 2021-03-26 | $200K | — | Filing → |